nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C19—Thalidomide—leprosy	0.14	0.169	CbGbCtD
Sitaxentan—CYP2C19—Rifampicin—leprosy	0.136	0.163	CbGbCtD
Sitaxentan—CYP2C9—Thalidomide—leprosy	0.116	0.14	CbGbCtD
Sitaxentan—CYP2C9—Rifampicin—leprosy	0.113	0.136	CbGbCtD
Sitaxentan—CYP2C19—Dapsone—leprosy	0.112	0.135	CbGbCtD
Sitaxentan—CYP2C9—Dapsone—leprosy	0.0931	0.112	CbGbCtD
Sitaxentan—CYP3A4—Rifampicin—leprosy	0.0656	0.079	CbGbCtD
Sitaxentan—CYP3A4—Dapsone—leprosy	0.0541	0.0652	CbGbCtD
Sitaxentan—Joint sprain—Dapsone—leprosy	0.0121	0.0713	CcSEcCtD
Sitaxentan—Ligament sprain—Dapsone—leprosy	0.00964	0.0566	CcSEcCtD
Sitaxentan—Skin necrosis—Thalidomide—leprosy	0.00357	0.021	CcSEcCtD
Sitaxentan—Dysaesthesia—Thalidomide—leprosy	0.00288	0.0169	CcSEcCtD
Sitaxentan—Proteinuria—Dapsone—leprosy	0.00277	0.0163	CcSEcCtD
Sitaxentan—Ascites—Thalidomide—leprosy	0.00274	0.0161	CcSEcCtD
Sitaxentan—Protein urine present—Dapsone—leprosy	0.00273	0.0161	CcSEcCtD
Sitaxentan—Raised liver function tests—Thalidomide—leprosy	0.0027	0.0159	CcSEcCtD
Sitaxentan—Paraesthesia oral—Thalidomide—leprosy	0.00266	0.0156	CcSEcCtD
Sitaxentan—Tongue discolouration—Thalidomide—leprosy	0.00258	0.0152	CcSEcCtD
Sitaxentan—Sinus bradycardia—Thalidomide—leprosy	0.00254	0.0149	CcSEcCtD
Sitaxentan—White blood cell count decreased—Thalidomide—leprosy	0.00251	0.0147	CcSEcCtD
Sitaxentan—Skin exfoliation—Dapsone—leprosy	0.00233	0.0137	CcSEcCtD
Sitaxentan—Venous thrombosis—Thalidomide—leprosy	0.00231	0.0136	CcSEcCtD
Sitaxentan—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00215	0.0126	CcSEcCtD
Sitaxentan—Psoriasis—Thalidomide—leprosy	0.00198	0.0117	CcSEcCtD
Sitaxentan—Oral candidiasis—Thalidomide—leprosy	0.00196	0.0115	CcSEcCtD
Sitaxentan—Hepatomegaly—Thalidomide—leprosy	0.00176	0.0103	CcSEcCtD
Sitaxentan—Metrorrhagia—Thalidomide—leprosy	0.00175	0.0103	CcSEcCtD
Sitaxentan—Cholestasis—Thalidomide—leprosy	0.00164	0.00964	CcSEcCtD
Sitaxentan—Pleural effusion—Thalidomide—leprosy	0.00163	0.00956	CcSEcCtD
Sitaxentan—Skin ulcer—Thalidomide—leprosy	0.0016	0.00941	CcSEcCtD
Sitaxentan—Hyperaesthesia—Thalidomide—leprosy	0.00159	0.00933	CcSEcCtD
Sitaxentan—Rash pustular—Thalidomide—leprosy	0.00156	0.00918	CcSEcCtD
Sitaxentan—Muscular weakness—Dapsone—leprosy	0.00156	0.00916	CcSEcCtD
Sitaxentan—Petechiae—Thalidomide—leprosy	0.00152	0.0089	CcSEcCtD
Sitaxentan—Endocrine disorder—Thalidomide—leprosy	0.0015	0.00883	CcSEcCtD
Sitaxentan—Proteinuria—Thalidomide—leprosy	0.00142	0.00834	CcSEcCtD
Sitaxentan—Amenorrhoea—Thalidomide—leprosy	0.00142	0.00834	CcSEcCtD
Sitaxentan—Protein urine present—Thalidomide—leprosy	0.0014	0.00822	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Dapsone—leprosy	0.00139	0.00819	CcSEcCtD
Sitaxentan—Musculoskeletal stiffness—Thalidomide—leprosy	0.00139	0.00816	CcSEcCtD
Sitaxentan—Viral infection—Thalidomide—leprosy	0.00138	0.00811	CcSEcCtD
Sitaxentan—Cellulitis—Thalidomide—leprosy	0.00137	0.00805	CcSEcCtD
Sitaxentan—Hyperbilirubinaemia—Thalidomide—leprosy	0.00137	0.00805	CcSEcCtD
Sitaxentan—Thinking abnormal—Thalidomide—leprosy	0.00136	0.008	CcSEcCtD
Sitaxentan—Hypocalcaemia—Thalidomide—leprosy	0.00136	0.008	CcSEcCtD
Sitaxentan—Herpes simplex—Thalidomide—leprosy	0.00135	0.00795	CcSEcCtD
Sitaxentan—Hypercholesterolaemia—Thalidomide—leprosy	0.00132	0.00774	CcSEcCtD
Sitaxentan—Sinusitis—Dapsone—leprosy	0.00128	0.00751	CcSEcCtD
Sitaxentan—Blood uric acid increased—Thalidomide—leprosy	0.00127	0.00746	CcSEcCtD
Sitaxentan—Pulmonary embolism—Thalidomide—leprosy	0.00125	0.00732	CcSEcCtD
Sitaxentan—Hyperkalaemia—Thalidomide—leprosy	0.00122	0.0072	CcSEcCtD
Sitaxentan—Eructation—Thalidomide—leprosy	0.00122	0.0072	CcSEcCtD
Sitaxentan—Colitis—Thalidomide—leprosy	0.0012	0.00703	CcSEcCtD
Sitaxentan—Candida infection—Thalidomide—leprosy	0.00119	0.00699	CcSEcCtD
Sitaxentan—Skin exfoliation—Thalidomide—leprosy	0.00119	0.00699	CcSEcCtD
Sitaxentan—Dry eye—Thalidomide—leprosy	0.00115	0.00676	CcSEcCtD
Sitaxentan—Tinnitus—Dapsone—leprosy	0.00114	0.0067	CcSEcCtD
Sitaxentan—Mental disability—Thalidomide—leprosy	0.00108	0.00636	CcSEcCtD
Sitaxentan—Gastroenteritis—Thalidomide—leprosy	0.00102	0.006	CcSEcCtD
Sitaxentan—Deafness—Thalidomide—leprosy	0.00101	0.00594	CcSEcCtD
Sitaxentan—Cardiac failure congestive—Thalidomide—leprosy	0.000998	0.00586	CcSEcCtD
Sitaxentan—Increased appetite—Thalidomide—leprosy	0.000963	0.00566	CcSEcCtD
Sitaxentan—Vertigo—Dapsone—leprosy	0.000957	0.00562	CcSEcCtD
Sitaxentan—Visual disturbance—Thalidomide—leprosy	0.000955	0.00561	CcSEcCtD
Sitaxentan—Arthritis—Thalidomide—leprosy	0.000931	0.00547	CcSEcCtD
Sitaxentan—Hypoglycaemia—Thalidomide—leprosy	0.000927	0.00545	CcSEcCtD
Sitaxentan—Cardiac failure—Thalidomide—leprosy	0.000927	0.00545	CcSEcCtD
Sitaxentan—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000905	0.00532	CcSEcCtD
Sitaxentan—Osteoarthritis—Thalidomide—leprosy	0.000905	0.00532	CcSEcCtD
Sitaxentan—Migraine—Thalidomide—leprosy	0.000891	0.00523	CcSEcCtD
Sitaxentan—Ataxia—Thalidomide—leprosy	0.000851	0.005	CcSEcCtD
Sitaxentan—Tachycardia—Dapsone—leprosy	0.000848	0.00498	CcSEcCtD
Sitaxentan—Blood creatinine increased—Thalidomide—leprosy	0.000848	0.00498	CcSEcCtD
Sitaxentan—Dehydration—Thalidomide—leprosy	0.000842	0.00494	CcSEcCtD
Sitaxentan—Liver function test abnormal—Thalidomide—leprosy	0.000836	0.00491	CcSEcCtD
Sitaxentan—Dry skin—Thalidomide—leprosy	0.00083	0.00487	CcSEcCtD
Sitaxentan—Orthostatic hypotension—Thalidomide—leprosy	0.000827	0.00486	CcSEcCtD
Sitaxentan—Breast disorder—Thalidomide—leprosy	0.000818	0.0048	CcSEcCtD
Sitaxentan—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000815	0.00479	CcSEcCtD
Sitaxentan—Cramp muscle—Thalidomide—leprosy	0.000815	0.00479	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Thalidomide—leprosy	0.000798	0.00469	CcSEcCtD
Sitaxentan—Muscular weakness—Thalidomide—leprosy	0.000798	0.00469	CcSEcCtD
Sitaxentan—Insomnia—Dapsone—leprosy	0.000786	0.00462	CcSEcCtD
Sitaxentan—Eosinophilia—Thalidomide—leprosy	0.000774	0.00455	CcSEcCtD
Sitaxentan—Angina pectoris—Thalidomide—leprosy	0.000762	0.00448	CcSEcCtD
Sitaxentan—Bronchitis—Thalidomide—leprosy	0.000752	0.00442	CcSEcCtD
Sitaxentan—Pancytopenia—Thalidomide—leprosy	0.000743	0.00436	CcSEcCtD
Sitaxentan—Pollakiuria—Thalidomide—leprosy	0.000723	0.00424	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Thalidomide—leprosy	0.000714	0.00419	CcSEcCtD
Sitaxentan—Weight decreased—Thalidomide—leprosy	0.000708	0.00416	CcSEcCtD
Sitaxentan—Hyperglycaemia—Thalidomide—leprosy	0.000706	0.00414	CcSEcCtD
Sitaxentan—Infestation NOS—Thalidomide—leprosy	0.000697	0.0041	CcSEcCtD
Sitaxentan—Infestation—Thalidomide—leprosy	0.000697	0.0041	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Thalidomide—leprosy	0.000688	0.00404	CcSEcCtD
Sitaxentan—Body temperature increased—Dapsone—leprosy	0.000687	0.00403	CcSEcCtD
Sitaxentan—Renal failure—Thalidomide—leprosy	0.000686	0.00403	CcSEcCtD
Sitaxentan—Myocardial infarction—Thalidomide—leprosy	0.000684	0.00402	CcSEcCtD
Sitaxentan—Stomatitis—Thalidomide—leprosy	0.00068	0.00399	CcSEcCtD
Sitaxentan—Conjunctivitis—Thalidomide—leprosy	0.000678	0.00398	CcSEcCtD
Sitaxentan—Haematuria—Thalidomide—leprosy	0.000665	0.00391	CcSEcCtD
Sitaxentan—Epistaxis—Thalidomide—leprosy	0.000658	0.00386	CcSEcCtD
Sitaxentan—Sinusitis—Thalidomide—leprosy	0.000654	0.00384	CcSEcCtD
Sitaxentan—Bradycardia—Thalidomide—leprosy	0.000637	0.00374	CcSEcCtD
Sitaxentan—Rhinitis—Thalidomide—leprosy	0.000628	0.00369	CcSEcCtD
Sitaxentan—Hepatitis—Thalidomide—leprosy	0.000626	0.00368	CcSEcCtD
Sitaxentan—Urinary tract disorder—Thalidomide—leprosy	0.000618	0.00363	CcSEcCtD
Sitaxentan—Oedema peripheral—Thalidomide—leprosy	0.000617	0.00362	CcSEcCtD
Sitaxentan—Urethral disorder—Thalidomide—leprosy	0.000614	0.00361	CcSEcCtD
Sitaxentan—Visual impairment—Thalidomide—leprosy	0.000603	0.00354	CcSEcCtD
Sitaxentan—Eye disorder—Thalidomide—leprosy	0.000585	0.00344	CcSEcCtD
Sitaxentan—Tinnitus—Thalidomide—leprosy	0.000584	0.00343	CcSEcCtD
Sitaxentan—Cardiac disorder—Thalidomide—leprosy	0.000581	0.00341	CcSEcCtD
Sitaxentan—Angiopathy—Thalidomide—leprosy	0.000568	0.00334	CcSEcCtD
Sitaxentan—Immune system disorder—Thalidomide—leprosy	0.000566	0.00332	CcSEcCtD
Sitaxentan—Mediastinal disorder—Thalidomide—leprosy	0.000564	0.00331	CcSEcCtD
Sitaxentan—Alopecia—Thalidomide—leprosy	0.000553	0.00325	CcSEcCtD
Sitaxentan—Vomiting—Dapsone—leprosy	0.000552	0.00325	CcSEcCtD
Sitaxentan—Mental disorder—Thalidomide—leprosy	0.000549	0.00322	CcSEcCtD
Sitaxentan—Malnutrition—Thalidomide—leprosy	0.000545	0.0032	CcSEcCtD
Sitaxentan—Headache—Dapsone—leprosy	0.000544	0.0032	CcSEcCtD
Sitaxentan—Tension—Thalidomide—leprosy	0.000535	0.00314	CcSEcCtD
Sitaxentan—Nervousness—Thalidomide—leprosy	0.000529	0.00311	CcSEcCtD
Sitaxentan—Muscle spasms—Thalidomide—leprosy	0.000524	0.00308	CcSEcCtD
Sitaxentan—Nausea—Dapsone—leprosy	0.000516	0.00303	CcSEcCtD
Sitaxentan—Tremor—Thalidomide—leprosy	0.000511	0.003	CcSEcCtD
Sitaxentan—Ill-defined disorder—Thalidomide—leprosy	0.000506	0.00297	CcSEcCtD
Sitaxentan—Anaemia—Thalidomide—leprosy	0.000504	0.00296	CcSEcCtD
Sitaxentan—Agitation—Thalidomide—leprosy	0.000501	0.00294	CcSEcCtD
Sitaxentan—Malaise—Thalidomide—leprosy	0.000492	0.00289	CcSEcCtD
Sitaxentan—Vertigo—Thalidomide—leprosy	0.00049	0.00288	CcSEcCtD
Sitaxentan—Leukopenia—Thalidomide—leprosy	0.000488	0.00287	CcSEcCtD
Sitaxentan—Chest pain—Thalidomide—leprosy	0.000464	0.00273	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000461	0.00271	CcSEcCtD
Sitaxentan—Discomfort—Thalidomide—leprosy	0.000458	0.00269	CcSEcCtD
Sitaxentan—Dry mouth—Thalidomide—leprosy	0.000454	0.00267	CcSEcCtD
Sitaxentan—Confusional state—Thalidomide—leprosy	0.000449	0.00263	CcSEcCtD
Sitaxentan—Oedema—Thalidomide—leprosy	0.000445	0.00261	CcSEcCtD
Sitaxentan—Infection—Thalidomide—leprosy	0.000442	0.0026	CcSEcCtD
Sitaxentan—Nervous system disorder—Thalidomide—leprosy	0.000436	0.00256	CcSEcCtD
Sitaxentan—Thrombocytopenia—Thalidomide—leprosy	0.000436	0.00256	CcSEcCtD
Sitaxentan—Tachycardia—Thalidomide—leprosy	0.000434	0.00255	CcSEcCtD
Sitaxentan—Skin disorder—Thalidomide—leprosy	0.000432	0.00254	CcSEcCtD
Sitaxentan—Anorexia—Thalidomide—leprosy	0.000424	0.00249	CcSEcCtD
Sitaxentan—Hypotension—Thalidomide—leprosy	0.000416	0.00244	CcSEcCtD
Sitaxentan—Insomnia—Thalidomide—leprosy	0.000402	0.00236	CcSEcCtD
Sitaxentan—Somnolence—Thalidomide—leprosy	0.000395	0.00232	CcSEcCtD
Sitaxentan—Dyspepsia—Thalidomide—leprosy	0.000392	0.0023	CcSEcCtD
Sitaxentan—Decreased appetite—Thalidomide—leprosy	0.000387	0.00227	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Thalidomide—leprosy	0.000384	0.00226	CcSEcCtD
Sitaxentan—Fatigue—Thalidomide—leprosy	0.000384	0.00225	CcSEcCtD
Sitaxentan—Pain—Thalidomide—leprosy	0.00038	0.00223	CcSEcCtD
Sitaxentan—Constipation—Thalidomide—leprosy	0.00038	0.00223	CcSEcCtD
Sitaxentan—Feeling abnormal—Thalidomide—leprosy	0.000367	0.00215	CcSEcCtD
Sitaxentan—Urticaria—Thalidomide—leprosy	0.000353	0.00208	CcSEcCtD
Sitaxentan—Body temperature increased—Thalidomide—leprosy	0.000352	0.00207	CcSEcCtD
Sitaxentan—Hypersensitivity—Thalidomide—leprosy	0.000328	0.00193	CcSEcCtD
Sitaxentan—Asthenia—Thalidomide—leprosy	0.000319	0.00187	CcSEcCtD
Sitaxentan—Diarrhoea—Thalidomide—leprosy	0.000304	0.00179	CcSEcCtD
Sitaxentan—Dizziness—Thalidomide—leprosy	0.000294	0.00173	CcSEcCtD
Sitaxentan—Vomiting—Thalidomide—leprosy	0.000283	0.00166	CcSEcCtD
Sitaxentan—Rash—Thalidomide—leprosy	0.00028	0.00165	CcSEcCtD
Sitaxentan—Dermatitis—Thalidomide—leprosy	0.00028	0.00165	CcSEcCtD
Sitaxentan—Headache—Thalidomide—leprosy	0.000279	0.00164	CcSEcCtD
Sitaxentan—Nausea—Thalidomide—leprosy	0.000264	0.00155	CcSEcCtD
